GlassScriptPhysician profile
Sumit M Khandhar
NPI 1174701668
$2,850.12
in general payments reported to CMS, 2019-2025
31 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $776 · 2020: $328 · 2021: $447 · 2022: $397 · 2023: $178 · 2024: $378 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $377.62 | 2020-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $266.64 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $212.28 | 2021-2023 | Verquvo |
| Abbott Laboratories | $203.08 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Shockwave Medical, INC | $201.99 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.72 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $164.22 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $159.69 | 2019-2020 | |
| Medtronic Vascular, INC. | $146.20 | 2019 | |
| Medtronic, INC. | $141.32 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.55 | 2024-2025 | |
| Venclose INC. | $89.39 | 2020 | |
| Pfizer INC. | $58.19 | 2019-2020 | |
| Boston Scientific Corporation | $55.46 | 2019-2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.89 | 2020-2024 | Jardiance |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $44.89 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $40.02 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $39.25 | 2024-2025 | Camzyos |
| Bardy Diagnostics, INC. | $30.43 | 2022 | |
| Amgen INC. | $30.02 | 2024-2025 | Repatha |
| Cardinal Health 200 LLC | $27.65 | 2021 | |
| Esperion Therapeutics, INC. | $26.08 | 2020-2021 | |
| Philips North America LLC | $25.15 | 2025 | Extended Holter |
| Atricure, INC. | $24.45 | 2024 | |
| Chiesi USA, INC. | $24.42 | 2019 | |
| Amarin Pharma, INC. | $23.47 | 2019 | |
| Edwards Lifesciences Corporation | $22.85 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cvrx, INC. | $22.07 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $20.02 | 2022 | |
| Cardiovascular Systems INC. | $19.99 | 2021 | |
| Astellas Pharma US INC | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Khandhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.